First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis

Basit Öğe Kaydı
dc.contributor.authorIsikdogan, A.
dc.contributor.authorTurk, H.
dc.contributor.authorBilir, C.
dc.contributor.authorSendur, M.
dc.contributor.authorKarabulut, B.
dc.contributor.authorArtac, M.
dc.contributor.authorCicin, I.
dc.date.accessioned2025-05-10T19:48:32Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionESMO 24th World Congress on Gastrointestinal Cancer -- JUN 29-JUL 02, 2022 -- Barcelona, SPAIN
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Soc Med Oncol
dc.description.sponsorshipAmgen
dc.description.sponsorshipAmgen.
dc.identifier.doi10.1016/j.annonc.2022.04.180
dc.identifier.endpageS281
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.scopusqualityQ1
dc.identifier.startpageS281
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2022.04.180
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11738
dc.identifier.volume33
dc.identifier.wosWOS:000823826500103
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.titleFirst-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis
dc.typeConference Object

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
11738.pdf
Boyut:
103.29 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu